Studies how adrenal gland tumors develop and tests new treatment options
Studies how adrenal tumors form and tests treatments in adrenocortical carcinoma patients.
Plain-language title generated from the registry record
Registry title: Adrenal Tumors - Pathogenesis and Therapy
Key facts
- Where
- Würzburg, GermanySee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people who have an adrenal tumor that was found on an imaging scan.
- Age
- Up to 100 years.
- Sex
- All sexes can join.
- Disease stage
- An adrenal tumor seen on imaging. No stage or type is named.
Read by machine on 12 November 2026.
Where in Germany
- University of WuerzburgWürzburg, GermanyContact: Martin Fassnacht, MDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- University of Wuerzburg
- Trial code
- NCT00669266
- Record updated
- 7 May 2026
- Original description
The pathogenesis of adrenal tumors is still not fully elucidated and the treatment options for malignant tumors are poor. The current study investigates different aspects of the pathogenesis of adrenal tumors and evaluates different therapeutic options in patients with adrenocortical carcinoma.Read full original descriptionShow less
Investigation of the Tumorigenesis of Adrenal Tumors and Evaluation of New Therapeutic Options - Untersuchungen Zur Tumorgenese Von Nebennierentumoren Und Evaluation Neuer Therapieoptionen
The pathogenesis of adrenal tumors is still not fully elucidated and the treatment options for malignant tumors are poor. The current study investigates different aspects of the pathogenesis of adrenal tumors and evaluates different therapeutic options in patients with adrenocortical carcinoma.
Inclusion: adrenal tumor detected by imaging.